USPTO serial 77575637
DRYDOS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCDOWELL, MATTHEW J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DRYDOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Norm J. Rich and Michele M. Simkin
NORM J. RICH AND MICHELE M. SIMKIN FOLEY & LARDNER LLP3000 K ST NW STE 500WASHINGTON, DC 20007-5143UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Oral pharmaceutical preparations used for the buccal delivery of drugs, namely, disintregratable mouth soluble tablets in the nature of antacids, antispasmodics and anti-ulcerants, anti-diarrheals, colorectal agents, cardiac drugs, CNS stimulants, analgesics, antipyretics and anti-inflammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, hyposensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, medical diagnostic reagents, anti-sense, oglionucleatides, mucosal vaccines, gene-based medicines, permeability and enhancing agents, and for the treatment of disorders of the central nervous system, dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 6, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 6, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 28, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| May 27, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 22, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 4, 2010 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 4, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 2, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 2, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 2, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 5, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 10, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 7, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 7, 2009 | ALIE | ASSIGNED TO LIE | — |
| Dec 22, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 22, 2008 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Dec 22, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 22, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 20, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2008 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Sep 25, 2008 | NWAP | NEW APPLICATION ENTERED | — |